{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:31:30Z","timestamp":1791225090885,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.jinf.2004.05.019","type":"journal-article","created":{"date-parts":[[2004,8,4]],"date-time":"2004-08-04T14:11:17Z","timestamp":1091628677000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Rifaximin\u2014a novel antimicrobial for enteric infections"],"prefix":"10.1016","volume":"50","author":[{"given":"David B.","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert L.","family":"DuPont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2004.05.019_BIB1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/338834","article-title":"Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)","volume":"185","author":"Jiang","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB2","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1093\/clinids\/12.Supplement_1.S73","article-title":"Epidemiology of travelers' diarrhea and relative importance of various pathogens","volume":"12","author":"Black","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.281.9.811","article-title":"Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica","volume":"281","author":"Steffen","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2004.05.019_BIB4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(00)02451-X","article-title":"Risk and aetiology of diarrhoea at various tourist destinations","volume":"356","author":"von Sonnenburg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2004.05.019_BIB5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJM199111143252006","article-title":"Diarrheal disease during operation desert shield","volume":"325","author":"Hyams","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.05.019_BIB6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/archinte.1988.00380110071015","article-title":"A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers' diarrhea","volume":"148","author":"Reves","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jinf.2004.05.019_BIB7","first-page":"1","article-title":"Persistent diarrhea in a traveling student","volume":"2","author":"DuPont","year":"1993","journal-title":"Gastrointest Dis Today"},{"key":"10.1016\/j.jinf.2004.05.019_BIB8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1572-0241.2003.07297.x","article-title":"Post-traveler's diarrhea irritable bowel syndrome: a prospective study","volume":"98","author":"Ilnyckyj","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB9","unstructured":"Okhuysen PC, Jiang ZD, Carlin L, Forbes C, DuPont HL. Frequency and characteristics of post infectious irritable bowel syndrome (IBS) in travelers to Mexico. 41st Annual Meeting of the Infectious Diseases Society of America 2003."},{"key":"10.1016\/j.jinf.2004.05.019_BIB10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/322644","article-title":"Reactive arthritis and Reiter's syndrome following an outbreak of gastroenteritis caused by Salmonella enteritidis","volume":"33","author":"Dworkin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB11","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJM199511233332102","article-title":"Campylobacter jejuni infection and Guillain\u2013Barre syndrome","volume":"333","author":"Rees","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.05.019_BIB12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","article-title":"Practice guidelines for the management of infectious diarrhea","volume":"32","author":"Guerrant","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB13","first-page":"1962","article-title":"Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology","volume":"92","author":"DuPont","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB14","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.45.1.212-216.2001","article-title":"In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions","volume":"45","author":"Gomi","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB15","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/clinids\/21.3.536","article-title":"Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent","volume":"21","author":"Kuschner","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB16","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199905203402001","article-title":"Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992\u20131998. Investigation Team","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.05.019_BIB17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/516303","article-title":"Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years","volume":"26","author":"Hoge","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/378746","article-title":"Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico","volume":"37","author":"Adachi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB19","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1056\/NEJM199306243282507","article-title":"Prevention and treatment of traveler's diarrhea","volume":"328","author":"DuPont","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2004.05.019_BIB20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0732-8893(93)90004-Q","article-title":"Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative","volume":"16","author":"Hoover","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/jac\/47.6.904","article-title":"In vitro activity of rifaximin against bacterial enteropathogens causing diarrhoea in children under 5 years of age in Ifakara, Tanzania","volume":"47","author":"Sierra","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB22","first-page":"365","article-title":"In vitro activity of rifaximin and rifampicin against some anaerobic bacteria","volume":"3","author":"Lamanna","year":"1984","journal-title":"Chemioterapia"},{"key":"10.1016\/j.jinf.2004.05.019_BIB23","first-page":"483","article-title":"In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp","volume":"13","author":"Ripa","year":"1987","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.jinf.2004.05.019_BIB24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000007297","article-title":"In vitro activity of rifaximin, metronidazole and vancomycin against Clostridium difficile and the rate of selection of spontaneously resistant mutants against representative anaerobic and aerobic bacteria, including ammonia-producing species","volume":"46","author":"Marchese","year":"2000","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jinf.2004.05.019_BIB25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/CMR.8.4.496","article-title":"Antimicrobial agent resistance in mycobacteria: molecular genetic insights","volume":"8","author":"Musser","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jinf.2004.05.019_BIB26","first-page":"1220","article-title":"Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial","volume":"44","author":"Gionchetti","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jinf.2004.05.019_BIB27","first-page":"51","article-title":"Pharmacokinetic study of rifaximin after oral administration in healthy volunteers","volume":"14","author":"Descombe","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.jinf.2004.05.019_BIB28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002280050426","article-title":"Rifaximin systemic absorption in patients with ulcerative colitis","volume":"54","author":"Rizzello","year":"1998","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB29","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","article-title":"In vitro activity and fecal concentration of rifaximin after oral administration","volume":"44","author":"Jiang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1159\/000007580","article-title":"Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea","volume":"59","author":"DuPont","year":"1998","journal-title":"Digestion"},{"key":"10.1016\/j.jinf.2004.05.019_BIB31","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/323814","article-title":"Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial","volume":"33","author":"DuPont","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB32","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1572-0241.2003.07283.x","article-title":"Therapy of travelers' diarrhea with rifaximin on various continents","volume":"98","author":"Steffen","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB33","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1093\/clind\/15.Supplement_1.S228","article-title":"Evaluation of new anti-infective drugs for the treatment of acute infectious diarrhea. Infectious Diseases Society of America and the Food and Drug Administration","volume":"15","author":"DuPont","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB34","first-page":"131","article-title":"Comparison of two non-absorbable antibiotics for treatment of bacterial enteritis in children","volume":"2","author":"Beseghi","year":"1998","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jinf.2004.05.019_BIB35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1185\/03007999709113341","article-title":"An open, controlled study of two non-absorbable antibiotics for the oral treatment of paediatric infectious diarrhoea","volume":"14","author":"Frisari","year":"1997","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jinf.2004.05.019_BIB36","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/030006058801600410","article-title":"Treatment of small intestine bacterial overgrowth with rifaximin, a non-absorbable rifamycin","volume":"16","author":"Corazza","year":"1988","journal-title":"J Int Med Res"},{"key":"10.1016\/j.jinf.2004.05.019_BIB37","first-page":"4","article-title":"Non-absorbable antibiotics and small bowel bacterial overgrowth","volume":"24","author":"Corazza","year":"1992","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB38","first-page":"1582","article-title":"Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics","volume":"49","author":"Cuoco","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jinf.2004.05.019_BIB39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/151.5.775","article-title":"The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli","volume":"151","author":"Karmali","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB40","first-page":"29","article-title":"Long-term treatment with rifaximin and lactobacilli in post-diverticulitic stenoses of the colon","volume":"15","author":"Giaccari","year":"1993","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2036.1999.00553.x","article-title":"Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis","volume":"13","author":"Gionchetti","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2004.05.019_BIB42","first-page":"101","article-title":"Prevention of infection in colonic surgery by rifaximin. A controlled, prospective, randomized trial","volume":"9","author":"Gruttadauria","year":"1987","journal-title":"Riv Eur Sci Med Farmacol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00384-002-0396-5","article-title":"Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon","volume":"18","author":"Latella","year":"2003","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1185\/03007999709113333","article-title":"Rifaximin, a non-absorbable rifamycin, for the treatment of hepatic encephalopathy. A double-blind, randomised trial","volume":"13","author":"Miglio","year":"1997","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jinf.2004.05.019_BIB45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042737-200012020-00012","article-title":"Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study","volume":"12","author":"Williams","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB46","doi-asserted-by":"crossref","DOI":"10.1111\/j.1469-0691.2004.00997.x","article-title":"Influence of rifaximin treatment on susceptibility of intestinal Gram-negative flora and enterococci","author":"DuPont","year":"2004","journal-title":"Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB47","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","author":"DeLeo","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.jinf.2004.05.019_BIB48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/clinids\/1.5.845","article-title":"Effects of subminimal inhibitory concentrations of antibiotics on adhesiveness of Escherichia coli in vitro","volume":"1","author":"Vosbeck","year":"1979","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB49","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1128\/AAC.3.4.456","article-title":"Relationships between curing of the F episome by rifampin and by acridine orange in Escherichia coli","volume":"3","author":"Riva","year":"1973","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB50","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/iai.28.3.923-926.1980","article-title":"Modification of bacterial serum susceptibility by rifampin","volume":"28","author":"Alexander","year":"1980","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2004.05.019_BIB51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1469-0691.1997.tb00272.x","article-title":"Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin","volume":"3","author":"Soro","year":"1997","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2004.05.019_BIB52","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/AAC.42.7.1853","article-title":"Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis","volume":"42","author":"Williams","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/jac\/42.5.621","article-title":"Relationship between antimycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis","volume":"42","author":"Yang","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB54","first-page":"371","article-title":"Antimycobacterial activity of rifaximin (L\/105) in experimental tuberculosis in the guinea pig","volume":"3","author":"Lucchesi","year":"1984","journal-title":"Chemioterapia"},{"key":"10.1016\/j.jinf.2004.05.019_BIB55","first-page":"82","article-title":"Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin","volume":"6","author":"Malvisi Stracciari","year":"1987","journal-title":"Chemioterapia"},{"key":"10.1016\/j.jinf.2004.05.019_BIB56","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1046\/j.1365-2036.2000.00808.x","article-title":"Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms","volume":"14","author":"Di Stefano","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2004.05.019_BIB57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-106-2-216","article-title":"Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial","volume":"106","author":"Ericsson","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2004.05.019_BIB58","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1128\/AAC.36.1.87","article-title":"Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study","volume":"36","author":"DuPont","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2004.05.019_BIB59","first-page":"403","article-title":"Rifaximine versus neomycin in the treatment of portosystemic encephalopathy","volume":"23","author":"Di Piazza","year":"1991","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.jinf.2004.05.019_BIB60","first-page":"105","article-title":"Rifaximin and Helicobacter pyloli eradication","volume":"1","author":"De Giorgio","year":"1997","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jinf.2004.05.019_BIB61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF01982198","article-title":"In vitro activity of rifaximin against Helicobacter pyroli","volume":"13","author":"Megraud","year":"1994","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2004.05.019_BIB62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1185\/03007999509111552","article-title":"Rifaximin in the treatment of chronic hepatic encephalopathy","volume":"13","author":"Puxeddu","year":"1995","journal-title":"Curr Med Res Opin"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445304001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445304001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:26:47Z","timestamp":1758986807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445304001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0163445304001197"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2004.05.019","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rifaximin\u2014a novel antimicrobial for enteric infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2004.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}